Breadcrumb

Breadcrumbs

Press Releases

Press Releases

News, Events, Updates, Breakthroughs

Press announcements are archived by release date, searchable by topic:

From To
Date Title
Wed Oct 04 00:00:00 GMT-04:00 2017
Daiichi Sankyo, Inc. Announces Commitments in Pain Care Program
PDF (330 KB)
Thu Sep 14 00:00:00 GMT-04:00 2017
MD Anderson and Daiichi Sankyo Enter Research Collaboration to Accelerate Development of Acute Myel ...
PDF (260 KB)
Mon Sep 11 00:00:00 GMT-04:00 2017
Daiichi Sankyo Presents New Data for DS-8201 in Multiple HER2-Expressing Solid Tumors at European S ...
PDF (213 KB)
Wed Sep 06 00:00:00 GMT-04:00 2017
Sanford Burnham Prebys and Daiichi Sankyo Announce Enrollment of First Subject in a Phase 1 Clinica ...
PDF (306 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabal ...
PDF (98 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Showcases New Insights on Multiple Oncology Compounds at the European Society for Me ...
PDF (230 KB)
Thu Aug 31 00:00:00 GMT-04:00 2017
Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories ...
PDF (27 KB)
Tue Aug 29 00:00:00 GMT-04:00 2017
Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic ...
PDF (179 KB)
Tue Aug 29 00:00:00 GMT-04:00 2017
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastati ...
PDF (178 KB)
Mon Aug 28 00:00:00 GMT-04:00 2017
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Select ...
PDF (256 KB)
Showing 1 - 10 of 41 results.

Press Release More Stories

More Stories

Who We Are

As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, Inc. draws on a rich heritage of innovation, integrity and accountability..

read more ...